Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GuCS: Genitourinary Cancers Symposium

2.

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

3.

Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors

4.

Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat

5.

FDA Approves Subcutaneous Isatuximab for MM Indications


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot